PFS Investments’s CVS Health CVS Stock Holding History

PFS Investments’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$42.1M	Buy	609,582 +40,924	+7%	+$2.91M	0.69%	39
2023 Q1	$44.1M	Buy	568,658 +52,442	+10%	+$4.4M	0.76%	33
2022 Q4	$48.1M	Buy	516,216 +41,911	+9%	+$4.04M	0.9%	19
2022 Q3	$45.2M	Buy	474,305 +44,900	+10%	+$4.44M	0.82%	11
2022 Q2	$39.8M	Buy	429,405 +67,939	+19%	+$6.63M	0.8%	23
2022 Q1	$36.6M	Buy	361,466 +47,933	+15%	+$5.04M	0.69%	35
2021 Q4	$32.3M	Buy	313,533 +30,979	+11%	+$2.86M	0.63%	44
2021 Q3	$26.5M	Buy	282,554 +24,318	+9%	+$2.04M	0.55%	51
2021 Q2	$21M	Buy	258,236 +24,940	+11%	+$2.04M	0.48%	57
2021 Q1	$17.6M	Buy	233,296 +32,425	+16%	+$2.36M	0.45%	63
2020 Q4	$15.3M	Buy	200,871 +26,202	+15%	+$1.7M	0.43%	66
2020 Q3	$10.2M	Buy	174,669 +33,796	+24%	+$2.1M	0.34%	74
2020 Q2	$9.15M	Buy	140,873 +27,786	+25%	+$1.75M	0.34%	67
2020 Q1	$6.71M	Buy	113,087 +17,057	+18%	+$1.14M	0.29%	63
2019 Q4	$7.13M	Buy	96,030 +25,178	+36%	+$1.77M	0.28%	70
2019 Q3	$4.47M	Buy	70,852 +21,049	+42%	+$1.25M	0.19%	78
2019 Q2	$2.77M	Buy	49,803 +27,835	+127%	+$1.5M	0.13%	76
2019 Q1	$1.19M	Buy	+21,968	New	+$1.36M	0.06%	80

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

PFS Investments's CVS Position: Q2 2023 in Review

PFS Investments increased its CVS Health (CVS) stake by 7.2% in Q2 2023, buying an estimated $2.91M and bringing the position to 609,582 shares worth $42.1M. The position accounts for 0.69% of the portfolio, ranked #39.

PFS Investments first reported a position in CVS in Q1 2019 and has held it in 18 quarters since. The position peaked at $48.1M in Q4 2022. 2,206 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

PFS Investments held 609,582 shares of CVS Health worth $42.1M as of Q2 2023.
PFS Investments bought 40,924 CVS Health shares in Q2 2023, an estimated $2.91M.
CVS Health made up 0.69% of PFS Investments's portfolio in Q2 2023, its #39 holding.
PFS Investments first reported a position in CVS Health in Q1 2019 and has held it in 18 quarters since.
PFS Investments's CVS Health position peaked at $48.1M in Q4 2022.
2,206 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.